Abingdon Health (LON:ABDX) Stock Price Up 2.1% – What’s Next?

Shares of Abingdon Health Plc (LON:ABDX) traded up 2.1% during mid-day trading on Tuesday . The company traded as high as GBX 12.50 and last traded at GBX 12.25. 362,867 shares were traded during mid-day trading, an increase of 14% from the average session volume of 317,975 shares. The stock had previously closed at GBX 12.

Abingdon Health Stock Performance

The company has a market cap of £31.38 million, a P/E ratio of -15.43 and a beta of 0.12. The company has a quick ratio of 1.96, a current ratio of 1.91 and a debt-to-equity ratio of 15.05. The business has a fifty day simple moving average of GBX 10.11 and a two-hundred day simple moving average of GBX 7.90.

Abingdon Health (LON:ABDX) last issued its quarterly earnings data on Tuesday, March 17th. The company reported GBX (0.43) earnings per share for the quarter. Abingdon Health had a negative return on equity of 55.91% and a negative net margin of 33.88%.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.